News about <![CDATA[NYSE:JNJ]]> News about en-us <![CDATA[3 Pharmaceuticals to Profit on Obamacare]]> More people enrolling in health insurance, that likely means more prescriptions and ultimately more profits for pharmaceuticals.

The post 3 Pharmaceuticals to Profit on Obamacare appeared first on InvestorPlace.

]]>
<![CDATA[3 Pharmaceuticals to Profit on Obamacare]]> ]]> <![CDATA[Charts Offer Hope a Major Correction Can Be Avoided]]> ]]> <![CDATA[Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson’s Management Discusses Q1 2014 Results – Earnings Call Transcript]]> [Seeking Alpha] – Good morning and welcome to the Johnson & Johnson First Quarter 2014 Earnings Conference Call. I would now like to turn the call over to Johnson & Johnson. I’m Louise . . . → Read More: Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson’s Management Discusses Q1 2014 Results – Earnings Call Transcript ]]> <![CDATA[Trading Range or Stock Correction?]]> Related posts:
  1. How To Monitor The Risk Of A Midterm-Election-Year Stock Correction [Dow Jones Industrial Average 2 Minute, iShares Russell 2000 Index (ETF), ProShares Ultra Russell2000 (ETF)]
  2. What To Do When Your 401(k) Doesn’t Offer ETFs [iShares Russell 2000 Index (ETF), SPDR Dow Jones Industrial Average ETF]
  3. How To Invest In A Stock Market Correction [Dow Jones Industrial Average 2 Minute(INDEXDJX:.DJI)]
  4. Market Correction Is Healthy For Stocks [Dow Jones Industrial Average 2 Minute(INDEXDJX:.DJI), SPDR Dow Jones Industrial Average ETF]
  5. Likelihood Of First Market Correction In Two Years Developing [Dow Jones Industrial Average 2 Minute, SPDR Dow Jones Industrial Average ETF]
]]>
<![CDATA[3 Blue Chips Climbing on Earnings (KO, JNJ, SCHW)]]> Earnings season is supposed to be a dud, but don't tell that to JNJ, SCHW or KO stock, all of which got a lift from Street-beating results.

The post 3 Blue Chips Climbing on Earnings (KO, JNJ, SCHW) appeared first on InvestorPlace.

]]>
<![CDATA[79 Ways to Refocus Your Earnings Season Investing Strategy]]> Q2 earnings season is officially in full swing, and here are my takes on 79 stocks based on our Portfolio Grader system.

The post 79 Ways to Refocus Your Earnings Season Investing Strategy appeared first on InvestorPlace.

]]>
<![CDATA[3 Blue Chips Climbing on Earnings (KO, JNJ, SCHW)]]> ]]> <![CDATA[79 Ways to Refocus Your Earnings Season Investing Strategy]]> ]]> <![CDATA[Stocks Defying The Stock Market Sell-Off?]]> Related posts:
  1. 5 Best Performing Dividend Yield Stocks [Kimberly Clark Corp, Merck & Co., Inc., Garmin Ltd., Johnson & Johnson, Lockheed Martin Corporation]
  2. How To Build A Portfolio To Reduce Risk [Johnson & Johnson, PepsiCo, Inc., Kimberly Clark Corp, Colgate-Palmolive Company]
  3. Why Investors Need To Keep A Close Eye On This Rail Stock [Union Pacific Corporation, Norfolk Southern Corp., CSX Corporation]
  4. Stocks The Broader Market Can’t Move Without [CSX Corporation, Union Pacific Corporation, Norfolk Southern Corp., Norfolk Southern Corp.]
  5. Time To Ditch Swinging Cyclicals? [Kimberly Clark Corp, CVS Caremark Corporation, The Clorox Co, Travelers Companies Inc]
]]>
<![CDATA[5 Stocks to Buy in April]]> The technicals say these blue chips are stocks to buy this month thanks to price momentum and seasonal strength. Here's a closer look.

The post 5 Stocks to Buy in April appeared first on InvestorPlace.

]]>
<![CDATA[Can Blue Chips Deliver?]]> Related posts:
  1. Dividend-Paying Blue Chips Are Still A Favorite [Johnson & Johnson, Halliburton Company, Delta Air Lines, Inc.]
  2. 5 Best Performing Dividend Yield Stocks [Kimberly Clark Corp, Merck & Co., Inc., Garmin Ltd., Johnson & Johnson, Lockheed Martin Corporation]
  3. Blue Chips Are The Cornerstone Of Portfolio Strategy [The Walt Disney Company, Nike Inc, CBS Corporation]
  4. Why These Companies Are So Attractive [Johnson & Johnson, The Walt Disney Company]
  5. Dividend Payers That Are Attractive Again [Cisco Systems, Inc., 3M Co, Johnson & Johnson, ConocoPhillips]
]]>
<![CDATA[5 Stocks to Buy in April]]> ]]> <![CDATA[5 Stocks Any New Parent Should Own]]> Related posts:
  1. Guide To A Solid and Profitable Portfolio [Johnson & Johnson, Nike Inc, The Procter & Gamble Company, 3M Co]
  2. Stocks To Buy During Period Of Low Interest Rates [The Procter & Gamble Company, General Electric Company, Knoll Inc]
  3. How To Play Lagging Consumer Staples Stocks [The Coca-Cola Company, The Procter & Gamble Company, Philip Morris International Inc.]
  4. Should Your Portfolio Strategy Focus On Geopolitical Events? [The Procter & Gamble Company, The Clorox Co, Zep, Inc.]
  5. The Procter & Gamble Company Earnings Put Consumer ETFs In Focus [Consumer Staples Select Sect. SPDR (ETF)]
]]>
<![CDATA[JNJ: A Little Leaner, But Is This Dividend Stalwart a Buy?]]> Johnson & Johnson's Ortho-Clinical sale is a bit of a head-scratcher, but it doesn't change the big picture much. JNJ stock still serves a purpose.

The post JNJ: A Little Leaner, But Is This Dividend Stalwart a Buy? appeared first on InvestorPlace.

]]>
<![CDATA[JNJ: A Little Leaner, But Is This Dividend Stalwart a Buy?]]> ]]> <![CDATA[Johnson & Johnson (NYSE:JNJ) | Johnson & Johnson Enters Agreement to be Official Healthcare Partner of the USO]]> [PR Newswire] – BETHESDA, Md., April 1, 2014 /PRNewswire/ — Johnson & Johnson (JNJ) announced it has entered a multi-year agreement to be the Official Healthcare Partner of the USO. The announcement was . . . → Read More: Johnson & Johnson (NYSE:JNJ) | Johnson & Johnson Enters Agreement to be Official Healthcare Partner of the USO ]]> <![CDATA[Dividend Stocks Providing for Consistent Cash Income]]> The beauty of owning a steady dividend stock portfolio is you don't have to keep a 24/7 watch on your portfolio. Here's how dividend stocks keep working for you

The post Dividend Stocks Providing for Consistent Cash Income appeared first on InvestorPlace.

]]>
<![CDATA[Dividend Stocks Providing for Consistent Cash Income]]> ]]> <![CDATA[Buy Johnson & Johnson Stock For the Yield, Not Growth]]> Welcome to the Stock of the Day. Healthcare and consumer goods giant Johnson & Johnson (JNJ) is dominating headlines today after it announced plans to sell its diagnostics unit to Carlyle Group (CG) for over $4 billion. Now that Johnson & Johnson is shedding its slow-growing business to focus on more profitable lines, is this...

The post Buy Johnson & Johnson Stock For the Yield, Not Growth appeared first on InvestorPlace.

]]>
<![CDATA[Buy Johnson & Johnson Stock For the Yield, Not Growth]]> ]]> <![CDATA[Choppy Market Testing Traders’ Patience]]> ]]> <![CDATA[Market Update (NYSE:JNJ): Johnson & Johnson to Webcast Annual Meeting of Shareholders]]> [PR Newswire] – Investors and other interested parties may access the live webcast of the meeting by visiting the Company’s website at www.jnj.com and clicking on the webcast icon. Caring for the world, . . . → Read More: Market Update (NYSE:JNJ): Johnson & Johnson to Webcast Annual Meeting of Shareholders ]]> <![CDATA[Company Update (NYSE:JNJ): Johnson & Johnson gets $1.2 billion Arkansas Risperdal judgment tossed out]]> [Reuters] – Johnson & Johnson on Thursday won a reversal by the Arkansas Supreme Court of a $1.2 billion judgment imposed after a jury concluded that the drugmaker improperly marketed its anti-psychotic drug . . . → Read More: Company Update (NYSE:JNJ): Johnson & Johnson gets $1.2 billion Arkansas Risperdal judgment tossed out ]]> <![CDATA[The 5 Best Index Funds for Optimists]]> ]]> <![CDATA[Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results]]> [PR Newswire] – NEW BRUNSWICK, N.J., March 11, 2014 /PRNewswire/ — Johnson & Johnson (JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 15th, to review . . . → Read More: Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results ]]> <![CDATA[Why I Use a P/E Below 20 for Evaluating Dividend Stocks]]> Long time readers know that I use a price earnings ratio of 20 as one of the parameters in my set of screening criteria for dividend stocks. Here's why...

The post Why I Use a P/E Below 20 for Evaluating Dividend Stocks appeared first on InvestorPlace.

]]>
<![CDATA[Why I Use a P/E Below 20 for Evaluating Dividend Stocks]]> ]]> <![CDATA[Coupons.com IPO: No Discount on This Deal]]> ]]> <![CDATA[3 Megacap Blue Chips You Don’t Want to Buy]]> It's hard not to love the stability of big, dividend-paying blue chips like Exxon Mobil. But for new money? Go ahead and take a pass.

The post 3 Megacap Blue Chips You Don’t Want to Buy appeared first on InvestorPlace.

]]>
<![CDATA[3 Megacap Blue Chips You Don’t Want to Buy]]> ]]> <![CDATA[5 Biotech Stocks That Are Buyout Candidates]]> These biotech stocks are this year's top M&A candidates. But even if they're not acquired, they're solid biopharma investments.

The post 5 Biotech Stocks That Are Buyout Candidates appeared first on InvestorPlace.

]]>
<![CDATA[Study: Tylenol in Pregnancy Linked to ADHD]]> ]]> <![CDATA[Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in 2014 Cowen 34th Annual Health Care Conference]]> [PR Newswire] – NEW BRUNSWICK, N.J., Feb. 25, 2014 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) will participate in the 2014 Cowen 34 th Annual Health Care Conference on Tuesday, Mar. 4, at . . . → Read More: Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in 2014 Cowen 34th Annual Health Care Conference ]]> <![CDATA[5 Biotech Stocks That Are Buyout Candidates]]> ]]> <![CDATA[Get Ready for the Next Dividend Stock Rush]]> Dividend stocks provide a nice buffer for investors with their payouts, however you still need to research the stock. Here are 17 dividend stocks to consider

The post Get Ready for the Next Dividend Stock Rush appeared first on InvestorPlace.

]]>
<![CDATA[Get Ready for the Next Dividend Stock Rush]]> ]]> <![CDATA[3 Types of Dividend Growth Stocks For Income Investors]]> In my experience as a dividend investor, I've identified three types of dividend growth stocks. Here are my definitions of those types, with examples of each.

The post 3 Types of Dividend Growth Stocks For Income Investors appeared first on InvestorPlace.

]]>
<![CDATA[3 Types of Dividend Growth Stocks For Income Investors]]> ]]> <![CDATA[The 3 Best Vanguard Funds for an Uncertain Market]]> ]]> <![CDATA[Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in 2014 Citi Global Health Care Conference]]> [PR Newswire] – NEW BRUNSWICK, N.J., Feb. 14, 2014 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) will participate in the 2014 Citi Global Health Care Conference on Monday, Feb. 24, at the Hilton . . . → Read More: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in 2014 Citi Global Health Care Conference ]]> <![CDATA[Stock Update: Johnson & Johnson (NYSE:JNJ) – J&J, Pharmacyclics drug gets U.S. approval for leukemia]]> [Reuters] – U.S. health regulators on Wednesday approved the Johnson & Johnson and Pharmacyclics Inc cancer drug Imbruvica to treat chronic lymphocytic leukemia, a slowly progressing form of blood cancer. The Food and . . . → Read More: Stock Update: Johnson & Johnson (NYSE:JNJ) – J&J, Pharmacyclics drug gets U.S. approval for leukemia ]]> <![CDATA[How To Build A Portfolio To Reduce Risk]]> Related posts:
  1. Guide To A Solid and Profitable Portfolio [Johnson & Johnson, Nike Inc, The Procter & Gamble Company, 3M Co]
  2. Why These Companies Are So Attractive [Johnson & Johnson, The Walt Disney Company]
  3. Dividend-Paying Blue Chips Are Still A Favorite [Johnson & Johnson, Halliburton Company, Delta Air Lines, Inc.]
  4. Dividend Payers That Are Attractive Again [Cisco Systems, Inc., 3M Co, Johnson & Johnson, ConocoPhillips]
  5. Consider Small-Cap Dividend Stocks In 2014 [Intel Corporation, Johnson & Johnson, ConocoPhillips]
]]>
<![CDATA[Why These Companies Are So Attractive]]> Related posts:
  1. Dividend Payers That Are Attractive Again [Cisco Systems, Inc., 3M Co, Johnson & Johnson, ConocoPhillips]
  2. Guide To A Solid and Profitable Portfolio [Johnson & Johnson, Nike Inc, The Procter & Gamble Company, 3M Co]
  3. Dividend-Paying Blue Chips Are Still A Favorite [Johnson & Johnson, Halliburton Company, Delta Air Lines, Inc.]
  4. Consider Small-Cap Dividend Stocks In 2014 [Intel Corporation, Johnson & Johnson, ConocoPhillips]
  5. Healthcare ETFs To Watch On Johnson & Johnson Report [Health Care SPDR (ETF)]
]]>
<![CDATA[Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson: Becoming Interesting Again For Investors]]> [at Seeking Alpha] – The recent market sell off has provided a lot of great entry points into dividend paying stocks, like the ones covered here and here. This article is about another . . . → Read More: Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson: Becoming Interesting Again For Investors ]]> <![CDATA[Dividend Payers That Are Attractive Again]]> Related posts:
  1. Consider Small-Cap Dividend Stocks In 2014 [Intel Corporation, Johnson & Johnson, ConocoPhillips]
  2. Dividend-Paying Blue Chips Are Still A Favorite [Johnson & Johnson, Halliburton Company, Delta Air Lines, Inc.]
  3. Cisco Systems, Inc. (CSCO): Getting Risk-Free Daily Income
  4. Cisco Systems, Inc.’s (CSCO) Bleak Outlook Hits Technology ETFs
  5. Facebook Inc (FB) and Cisco Systems, Inc. (CSCO) Enter Into A Partnership
]]>
<![CDATA[Guide To A Solid and Profitable Portfolio]]> Related posts:
  1. Stocks To Buy During Period Of Low Interest Rates [The Procter & Gamble Company, General Electric Company, Knoll Inc]
  2. Dividend-Paying Blue Chips Are Still A Favorite [Johnson & Johnson, Halliburton Company, Delta Air Lines, Inc.]
  3. The Procter & Gamble Company Earnings Put Consumer ETFs In Focus [Consumer Staples Select Sect. SPDR (ETF)]
  4. Consider Small-Cap Dividend Stocks In 2014 [Intel Corporation, Johnson & Johnson, ConocoPhillips]
  5. Expect Solid Auto Sales This Year [Ford Motor Company, General Motors Company]
]]>
<![CDATA[Company Update: Johnson & Johnson (NYSE:JNJ) – The Leukemia Race: Gilead Vs. Johnson & Johnson, Roche]]> [at Seeking Alpha] – Last November the FDA approved Imbruvica, a drug made by Pharmacyclics ( PCYC ) and Johnson and Johnson’s ( JNJ ) for the treatment of MCL (mantle-cell lymphoma) but . . . → Read More: Company Update: Johnson & Johnson (NYSE:JNJ) – The Leukemia Race: Gilead Vs. Johnson & Johnson, Roche ]]> <![CDATA[JNJ: Johnson & Johnson Stock Enters Oversold Territory]]> ]]> <![CDATA[Emerging Market Turmoil Gives Rally Frostbite]]> ]]>